Brookstone Capital Management Increases Stake in McKesson Corporation $MCK

Brookstone Capital Management increased its stake in McKesson Corporation (NYSE:MCK) by 18.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,821 shares of the company’s stock after buying an additional 2,187 shares during the period. Brookstone Capital Management’s holdings in McKesson were worth $11,337,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the company. J.W. Cole Advisors Inc. grew its position in shares of McKesson by 35.3% in the 3rd quarter. J.W. Cole Advisors Inc. now owns 5,089 shares of the company’s stock worth $3,931,000 after buying an additional 1,329 shares during the period. Cullen Investment Group LTD. lifted its position in McKesson by 550.4% during the 4th quarter. Cullen Investment Group LTD. now owns 4,670 shares of the company’s stock valued at $3,811,000 after acquiring an additional 3,952 shares during the period. Private Wealth Partners LLC lifted its position in McKesson by 5.6% during the 3rd quarter. Private Wealth Partners LLC now owns 31,841 shares of the company’s stock valued at $24,598,000 after acquiring an additional 1,682 shares during the period. AlphaQuest LLC boosted its stake in McKesson by 91.2% during the third quarter. AlphaQuest LLC now owns 1,767 shares of the company’s stock worth $1,365,000 after acquiring an additional 843 shares in the last quarter. Finally, CW Advisors LLC grew its holdings in McKesson by 282.5% in the second quarter. CW Advisors LLC now owns 11,008 shares of the company’s stock worth $8,067,000 after purchasing an additional 8,130 shares during the period. 85.07% of the stock is owned by institutional investors.

Insider Activity

In other news, EVP Thomas L. Rodgers sold 276 shares of the firm’s stock in a transaction on Monday, January 5th. The stock was sold at an average price of $816.18, for a total value of $225,265.68. Following the transaction, the executive vice president directly owned 2,268 shares in the company, valued at $1,851,096.24. This trade represents a 10.85% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the company’s stock in a transaction on Friday, February 6th. The shares were sold at an average price of $955.00, for a total value of $313,240.00. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 3,868 shares of company stock worth $3,743,820. Insiders own 0.08% of the company’s stock.

McKesson Stock Up 0.6%

Shares of NYSE MCK opened at $864.99 on Wednesday. The firm’s 50-day moving average price is $908.89 and its 200-day moving average price is $842.77. McKesson Corporation has a 52-week low of $637.00 and a 52-week high of $999.00. The company has a market cap of $105.95 billion, a PE ratio of 24.88, a PEG ratio of 1.38 and a beta of 0.38.

McKesson (NYSE:MCK) last released its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, beating the consensus estimate of $9.19 by $0.15. The firm had revenue of $106.16 billion during the quarter, compared to analysts’ expectations of $105.98 billion. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The firm’s quarterly revenue was up 11.4% on a year-over-year basis. During the same period in the previous year, the company earned $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, equities research analysts anticipate that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be issued a dividend of $0.82 per share. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. The ex-dividend date of this dividend is Monday, March 2nd. McKesson’s dividend payout ratio is presently 9.43%.

Wall Street Analyst Weigh In

MCK has been the subject of a number of analyst reports. Wells Fargo & Company raised their target price on shares of McKesson from $914.00 to $925.00 and gave the company an “equal weight” rating in a research note on Thursday, February 5th. Barclays upped their price target on McKesson from $960.00 to $1,050.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 18th. Wall Street Zen raised McKesson from a “hold” rating to a “buy” rating in a research report on Sunday, March 22nd. Robert W. Baird set a $968.00 target price on McKesson in a report on Wednesday, January 14th. Finally, Weiss Ratings downgraded McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a report on Thursday, February 5th. Thirteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, McKesson currently has a consensus rating of “Moderate Buy” and an average target price of $960.93.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.